Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-28
2000-09-26
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514317, 514424, 514529, 514578, 514613, A61K 3147, A61K 31445, A61K 3140
Patent
active
061243140
ABSTRACT:
This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
REFERENCES:
patent: 3987091 (1976-10-01), Cragoe, Jr. et al.
patent: 3991087 (1976-11-01), Cragoe, Jr. et al.
patent: 4033996 (1977-07-01), Cragoe, Jr. et al.
patent: 4066692 (1978-01-01), Cragoe, Jr. et al.
patent: 4091107 (1978-05-01), Cragoe, Jr. et al.
patent: 4092356 (1978-05-01), Cragoe, Jr. et al.
patent: 4097504 (1978-06-01), Cragoe, Jr. et al.
patent: 4112236 (1978-09-01), Bicking et al.
Cameron Kimberly O.
Lefker Bruce A.
Rosati Robert L.
Benson Gregg C.
Davis Zinna Northington
Pfizer Inc.
Richardson Peter C.
Ronau Robert T.
LandOfFree
Osteoporosis compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osteoporosis compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteoporosis compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100537